Clinical Trial

AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer

Study acronym: AI-SONAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 24, 2022 (before its estimated November 1, 2022 completion). Its status may not reflect the trial's current state.
Summary
This study will assess the utility of radiomics and artificial intelligence approaches to new lung nodules in patients who have undergone radical treatment for a previous cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-05-10.
Trial Details
NCT Number NCT05375591
Lead Sponsor Royal Marsden NHS Foundation Trust
Collaborators: Institute of Cancer Research, United Kingdom, National Institute for Health Research, United Kingdom, Royal Brompton & Harefield NHS Foundation Trust, Royal Marsden Partners Cancer Alliance, Imperial College London, Oxford University Hospitals NHS Trust, National Heart and Lung Institute
Conditions Indeterminate Pulmonary Nodules, Lung Metastases, Second Primary Cancer, Lung Cancer
Enrollment 1,000 participants
Start Date 2021-10-13
Primary Completion 2022-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2022-05-24